We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+8.41%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.54B
AUM Growth
-$44M
Cap. Flow
-$103M
Cap. Flow %
-6.66%
Top 10 Hldgs %
10.05%
Holding
662
New
91
Increased
91
Reduced
211
Closed
114

Top Buys

Rank Stock Value
1
FMC icon
FMC
FMC
+$11.1M
2
LVS icon
Las Vegas Sands
LVS
+$9.43M
3
EXPE icon
Expedia Group
EXPE
+$8.63M
4
TXN icon
Texas Instruments
TXN
+$8.41M
5
TRU icon
TransUnion
TRU
+$8.01M

Top Sells

Rank Stock Value
1
STX icon
Seagate
STX
+$12.9M
2
WDC icon
Western Digital
WDC
+$11.6M
3
VSAT icon
Viasat
VSAT
+$10.2M
4
CPNG icon
Coupang
CPNG
+$9.66M
5
CLS icon
Celestica
CLS
+$5.93M

Sector Composition

Rank Sector Weight
1 Technology 17.6%
2 Consumer Discretionary 16.55%
3 Healthcare 14.73%
4 Industrials 14.64%
5 Financials 11.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTSI icon
201
MACOM Technology Solutions
MTSI
$20.1B
$2.7M 0.18%
15,777
AS icon
202
Amer Sports
AS
$20.5B
$2.69M 0.17%
71,983
-22,274
-24% -$764K
MXL icon
203
MaxLinear
MXL
$5.88B
$2.66M 0.17%
152,748
-21,478
-12% -$350K
DOLE icon
204
Dole
DOLE
$1.34B
$2.66M 0.17%
177,591
AGNT
205
AGNT Inc
AGNT
$690M
$2.66M 0.17%
294,078
-37,386
-11% -$395K
KW
206
DELISTED
Kennedy-Wilson Holdings
KW
$2.66M 0.17%
274,803
-132,049
-32% -$1.18M
CLDX icon
207
Celldex Therapeutics
CLDX
$2.8B
$2.66M 0.17%
97,822
RVLV icon
208
Revolve Group
RVLV
$1.84B
$2.62M 0.17%
86,749
TMUS icon
209
T-Mobile US
TMUS
$190B
$2.6M 0.17%
12,800
-3,700
-22% -$784K
AVPT icon
210
AvePoint
AVPT
$2.72B
$2.56M 0.17%
184,535
-22,100
-11% -$305K
TFII icon
211
TFI International
TFII
$12B
$2.55M 0.17%
24,661
-7,079
-22% -$659K
GE icon
212
GE Aerospace
GE
$375B
$2.5M 0.16%
+8,100
New +$2.44M
PGNY icon
213
Progyny
PGNY
$2.47B
$2.46M 0.16%
95,839
-166,555
-63% -$3.83M
HUM icon
214
Humana
HUM
$45.8B
$2.43M 0.16%
+9,490
New +$2.49M
CBRL icon
215
Cracker Barrel
CBRL
$1.17B
$2.43M 0.16%
+95,675
New +$3.06M
ARCO icon
216
Arcos Dorados Holdings
ARCO
$1.75B
$2.43M 0.16%
330,780
-107,686
-25% -$775K
TNDM icon
217
Tandem Diabetes Care
TNDM
$1.18B
$2.43M 0.16%
110,385
-60,035
-35% -$1.08M
IRDM icon
218
Iridium Communications
IRDM
$4.87B
$2.4M 0.16%
138,207
+47,981
+53% +$848K
IMO icon
219
Imperial Oil
IMO
$60.8B
$2.4M 0.16%
27,761
PAGS icon
220
PagSeguro Digital
PAGS
$2.62B
$2.38M 0.15%
247,387
-220,936
-47% -$2.12M
SFD
221
Smithfield Foods
SFD
$10.5B
$2.38M 0.15%
106,528
ATMU icon
222
Atmus Filtration Technologies
ATMU
$4.43B
$2.37M 0.15%
45,616
-2,500
-5% -$121K
TALO icon
223
Talos Energy
TALO
$2.36B
$2.36M 0.15%
214,408
MATV icon
224
Mativ Holdings
MATV
$455M
$2.36M 0.15%
194,374
+16,302
+9% +$192K
CW icon
225
Curtiss-Wright
CW
$27.5B
$2.34M 0.15%
4,239

Similar funds

PDT Partners's Q4 2025 Portfolio in Review

As of Q4 2025, PDT Partners held 662 positions worth $1.54B, down 2.8% from $1.59B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

PDT Partners withdrew a net $103M in Q4 2025, closing 114 positions and reducing 211 holdings. Its most notable exit was Seagate, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, PDT Partners opened a new position in FMC worth $8.09M.

  • PDT Partners's largest Q4 2025 buy was FMC: 583,388 shares worth $8.09M.
  • PDT Partners added most to Las Vegas Sands in Q4 2025, an estimated $9.43M increase.
  • PDT Partners's biggest Q4 2025 reduction was Viasat, cutting an estimated $10.2M.
  • PDT Partners fully exited Seagate in Q4 2025, selling an estimated $12.9M.
  • PDT Partners's ten largest holdings make up 10% of its $1.54B portfolio in Q4 2025.
  • PDT Partners opened 91 new positions and closed 114 in Q4 2025.
  • PDT Partners's portfolio value fell 2.8% quarter-over-quarter to $1.54B.

Based on PDT Partners's 13F filing for Q4 2025, filed 17 Feb 2026.